<DOC>
	<DOCNO>NCT01698307</DOCNO>
	<brief_summary>Assess implementation enhance treatment algorithm improve management Crohn 's Disease compare conventional Step-care approach .</brief_summary>
	<brief_title>Enhanced Algorithm Crohn 's Treatment Incorporating Early Combination Therapy</brief_title>
	<detailed_description>Crohn 's disease ( CD ) chronic inflammatory disorder gastrointestinal tract . During disease exacerbation , pharmacological surgical intervention usually need re-establish remission . Ideally , strategies employ maintain patient long-term remission minimize exposure corticosteroid reduce therapy-related toxicity . Nevertheless , reality many patient CD receive effective therapy disease often remain active , lead uncontrolled inflammation complication either underlying disease corticosteroid .</detailed_description>
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<mesh_term>Antimetabolites</mesh_term>
	<criteria>Documented diagnosis CD Written inform consent must obtain documented . Willing utilize study supply adalimumab provide syringe format , indicate accord treatment algorithm . Any condition ( e.g. , history alcohol substance abuse ) , opinion investigator , may interfere patient 's ability comply study procedure . Latex allergy condition adalimumab syrinx contraindicate Currently participate , plan participate study involve investigational product within 12 month may interfere patient 's ability comply study procedure . Previously fail class tumor necrosis factor ( TNF ) antagonists treatment CD . Diagnosis short bowel syndrome</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Crohn 's Disease</keyword>
	<keyword>Deep Remission</keyword>
	<keyword>Complications</keyword>
</DOC>